Literature DB >> 16380496

Natural antibiotics and insulin sensitivity: the role of bactericidal/permeability-increasing protein.

Carme Gubern1, Abel López-Bermejo, Josefina Biarnés, Joan Vendrell, Wifredo Ricart, José Manuel Fernández-Real.   

Abstract

The innate immune system can immediately respond to microorganism intrusion by helping to prevent further invasion. Bactericidal/permeability-increasing protein (BPI) is a major constituent of neutrophils that possesses anti-inflammatory properties. Inflammation is increasingly recognized as a component of the metabolic syndrome. We hypothesized that the production of BPI could be linked to insulin sensitivity and glucose tolerance. We studied circulating BPI across categories of glucose tolerance. We also studied whether these cross-sectional associations were of functional importance. For this reason, we investigated circulating bioactive lipopolysaccharide and the effects of changing insulin action-after treatment with an insulin sensitizer (metformin)-on circulating BPI in subjects with glucose intolerance. Finally, we tested whether a 3'-untranslated region (UTR) BPI polymorphism led to differences in BPI and insulin action among nondiabetic subjects. Age- and BMI-adjusted circulating BPI was significantly lower among patients with type 2 diabetes. Circulating BPI correlated negatively with fasting and postload glucose and insulin concentrations. In subjects with glucose intolerance, BPI was also linked to BMI, waist-to-hip ratio, and age- and BMI-adjusted insulin sensitivity. Bioactive lipopolysaccharide was negatively correlated with circulating BPI (r = -0.57, P < 0.0001) and positively with plasma lipopolysaccharide-binding protein (r = 0.54, P = 0.002). In parallel to improved insulin sensitivity, plasma BPI significantly increased in the metformin group but not in the placebo group. A 3'-UTR BPI polymorphism was simultaneously associated with plasma BPI concentration, waist-to-hip ratio, fasting and postload insulin concentration, fasting plasma triglycerides, and insulin sensitivity. These findings suggest that this component of the innate immune system is associated with metabolic pathways.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16380496

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  30 in total

1.  Activity optimization of an undecapeptide analogue derived from a frog-skin antimicrobial peptide.

Authors:  Hyung-Sik Won; Su-Jin Kang; Wahn-Soo Choi; Bong-Jin Lee
Journal:  Mol Cells       Date:  2010-11-23       Impact factor: 5.034

2.  Circulating osteocalcin concentrations are associated with parameters of liver fat infiltration and increase in parallel to decreased liver enzymes after weight loss.

Authors:  J M Fernández-Real; F Ortega; J Gómez-Ambrosi; J Salvador; G Frühbeck; W Ricart
Journal:  Osteoporos Int       Date:  2010-03-04       Impact factor: 4.507

Review 3.  Resistance to type 2 diabetes mellitus: a matter of hormesis?

Authors:  Hubert Kolb; Décio L Eizirik
Journal:  Nat Rev Endocrinol       Date:  2011-10-25       Impact factor: 43.330

4.  Gene prioritization in Type 2 Diabetes using domain interactions and network analysis.

Authors:  Amitabh Sharma; Sreenivas Chavali; Rubina Tabassum; Nikhil Tandon; Dwaipayan Bharadwaj
Journal:  BMC Genomics       Date:  2010-02-02       Impact factor: 3.969

5.  Overview of glycemic control in critical care: relating performance and clinical results.

Authors:  J Geoffrey Chase; Christopher E Hann; Geoffrey M Shaw; Jason Wong; Jessica Lin; Thomas Lotz; Aaron Lecompte; Timothy Lonergan
Journal:  J Diabetes Sci Technol       Date:  2007-01

6.  Targeting the association of calgranulin B (S100A9) with insulin resistance and type 2 diabetes.

Authors:  Francisco J Ortega; Josep M Mercader; José M Moreno-Navarrete; Mónica Sabater; Neus Pueyo; Sergio Valdés; Bartomeu Ruiz; Elodie Luche; Matteo Serino; Deborah Naon; Wifredo Ricart; Patricia Botas; Elias Delgado; Remy Burcelin; Gema Frühbeck; Fatima Bosch; Gertrude Mingrone; Antonio Zorzano; José M Fernández-Real
Journal:  J Mol Med (Berl)       Date:  2012-12-04       Impact factor: 4.599

7.  Endotoxin-directed innate immunity in tracheal aspirates of mechanically ventilated human neonates.

Authors:  Katheryn E Nathe; Richard Parad; Linda J Van Marter; Cara A Lund; Eugénie E Suter; Sonia Hernandez-diaz; Elizabeth B G Boush; Eva Ikonomu; Leighanne Gallington; Jo Ann Morey; Alenka M Zeman; Meaghan Mcnamara; Ofer Levy
Journal:  Pediatr Res       Date:  2009-08       Impact factor: 3.756

8.  Identification of single nucleotide polymorphisms in hematopoietic cell transplant patients affecting early recognition of, and response to, endotoxin.

Authors:  Eva C Guinan; Christine D Palmer; Christy J Mancuso; Lisa Brennan; Liat Stoler-Barak; Leslie A Kalish; Eugenie E Suter; Leighanne C Gallington; David P Huhtelin; Maria Mansilla; Ralf R Schumann; Jeffrey C Murray; Jerrold Weiss; Ofer Levy
Journal:  Innate Immun       Date:  2013-10-09       Impact factor: 2.680

Review 9.  Treating prediabetes with metformin: systematic review and meta-analysis.

Authors:  Muriel Lily; Muriel Lilly; Marshall Godwin
Journal:  Can Fam Physician       Date:  2009-04       Impact factor: 3.275

10.  Increase in plasma endotoxin concentrations and the expression of Toll-like receptors and suppressor of cytokine signaling-3 in mononuclear cells after a high-fat, high-carbohydrate meal: implications for insulin resistance.

Authors:  Husam Ghanim; Sanaa Abuaysheh; Ching Ling Sia; Kelly Korzeniewski; Ajay Chaudhuri; Jose Manuel Fernandez-Real; Paresh Dandona
Journal:  Diabetes Care       Date:  2009-09-15       Impact factor: 17.152

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.